The renin-angiotensin system (RAS) remains a cornerstone of cardiovascular and renal physiology, orchestrating vital aspects of blood pressure regulation and fluid-electrolyte balance.

Kurdi, Amanj, Tanja Mueller, and Natalie Weir. 2022. “An Umbrella Review and Meta‐Analysis of Renin–Angiotensin System Drugs Use and COVID ‐19 Outcomes.” ...

Two new studies have been published that further focus attention on how the renin–angiotensin system — and specifically the ACE2 receptor — may be involved in COVID-19 infection.

COMMENTARY Inhibition of the Renin Angiotensin Aldosterone System in Black Populations -- Does It or Doesn't It Work? Janice G. Douglas, MD Disclosures July 07, 2004 ...

Quick Take Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19 June 17, 2020 DOI: 10.1056/NEJMdo005778 Save ...

The renin-angiotensin-aldosterone system (RAAS) is a pivotal hormone system in regulating blood pressure and fluid balance. It comprises of three hormones – renin, angiotensin II, and aldosterone.

Discontinuing or reducing renin-angiotensin-aldosterone system inhibitor treatment may have negative outcomes for patients with hyperkalemia, but it is a common practice in many clinics, according ...

Intrarenal renin-angiotensin system in hypertensive patients with localized kidney cancer. Authors: Roman Osokin, Ekaterina Komarova, Igor Aboyan, Aleksey Yu. Maksimov, Roman Ischenko, Olga Shatova, ...

Renin-angiotensin system drugs: dual therapy Key therapeutic topic KTT2 Published: 15 January 2015 Last updated: 26 February 2016 ...

Cite this: Inhibition of the Renin Angiotensin Aldosterone System in Black Populations -- Does It or Doesn't It Work? - Medscape - Jul 08, 2004. Unique Characteristics of Hypertension in Blacks That ...

Reynolds et al. 11 conducted a study based on data from the electronic health records of 12,594 patients in the New York University (NYU) Langone Health system who were tested for Covid-19 between ...